Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP285264.RAIFyql6OZaHxs41M1HnsF5Qc2djFzAagbYadCh6FZdno130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP285264.RAIFyql6OZaHxs41M1HnsF5Qc2djFzAagbYadCh6FZdno130_assertion type Assertion NP285264.RAIFyql6OZaHxs41M1HnsF5Qc2djFzAagbYadCh6FZdno130_head.
- NP285264.RAIFyql6OZaHxs41M1HnsF5Qc2djFzAagbYadCh6FZdno130_assertion description "[Multivariate analysis also showed that ERCC1 mRNA level was a potential predictor for relapse and survival in gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy (P<0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP285264.RAIFyql6OZaHxs41M1HnsF5Qc2djFzAagbYadCh6FZdno130_provenance.
- NP285264.RAIFyql6OZaHxs41M1HnsF5Qc2djFzAagbYadCh6FZdno130_assertion evidence source_evidence_literature NP285264.RAIFyql6OZaHxs41M1HnsF5Qc2djFzAagbYadCh6FZdno130_provenance.
- NP285264.RAIFyql6OZaHxs41M1HnsF5Qc2djFzAagbYadCh6FZdno130_assertion SIO_000772 19009659 NP285264.RAIFyql6OZaHxs41M1HnsF5Qc2djFzAagbYadCh6FZdno130_provenance.
- NP285264.RAIFyql6OZaHxs41M1HnsF5Qc2djFzAagbYadCh6FZdno130_assertion wasDerivedFrom befree-20140225 NP285264.RAIFyql6OZaHxs41M1HnsF5Qc2djFzAagbYadCh6FZdno130_provenance.
- NP285264.RAIFyql6OZaHxs41M1HnsF5Qc2djFzAagbYadCh6FZdno130_assertion wasGeneratedBy ECO_0000203 NP285264.RAIFyql6OZaHxs41M1HnsF5Qc2djFzAagbYadCh6FZdno130_provenance.